Toward advances in retinoblastoma genetics in Kenya.

Autor: Dimaras H; Department of Ophthalmology and Vision Sciences, Faculty of Medicine, The University of Toronto, Toronto, Ontario, Canada. helen.dimaras@sickkids.ca.; Division of Clinical Public Health, Dalla Lana School of Public Health, The University of Toronto, Toronto, Ontario, Canada. helen.dimaras@sickkids.ca.; Department of Ophthalmology and Vision Sciences, The Hospital for Sick Children, Toronto, Ontario, Canada. helen.dimaras@sickkids.ca.; Child Health Evaluative Sciences Program, SickKids Research Institute, Toronto, Ontario, Canada. helen.dimaras@sickkids.ca.; Centre for Global Child Health, SickKids Research Institute, Toronto, Ontario, Canada. helen.dimaras@sickkids.ca., Omweri B; Department of Human Pathology, University of Nairobi, Nairobi, Kenya., Muema D; KAVI Institute of Clinical Research, Nairobi, Kenya., Kanda L; KAVI Institute of Clinical Research, Nairobi, Kenya., Macharia RW; Department of Biochemistry, University of Nairobi, Nairobi, Kenya., Gitau J; Directorate of Research and Innovation, Mount Kenya University, Thika, Kenya., Mutinda C; Department of Pediatrics and Child Health, University of Nairobi, Nairobi, Kenya.; Pumwani Maternity Hospital, Nairobi City County Medical Services, Nairobi, Kenya.; Scientific Ethics Review Unit, Kenya Medical Research Institute, Nairobi, Kenya., Kimani K; Department of Ophthalmology, University of Nairobi, Nairobi, Kenya.; Kenyatta National Hospital, Nairobi, Kenya., Waweru W; Department of Human Pathology, University of Nairobi, Nairobi, Kenya.; Kenyatta National Hospital, Nairobi, Kenya., Gichuhi S; Department of Ophthalmology, University of Nairobi, Nairobi, Kenya., Mureithi MW; Department of Medical Microbiology and Immunology, University of Nairobi, Nairobi, Kenya., Njambi L; Department of Ophthalmology, University of Nairobi, Nairobi, Kenya. drnjambi@uonbi.ac.ke.; Kenyatta National Hospital, Nairobi, Kenya. drnjambi@uonbi.ac.ke.

Publikováno v: Nature genetics [Nat Genet] 2024 Nov 11. Date of Electronic Publication: 2024 Nov 11.

Development and preliminary evaluation of a genetics education booklet for retinoblastoma.

Autor: Irvine T; The Humanities Program, The University of Toronto, Toronto, Ontario, Canada., Brundage M; Human Biology Program, The University of Toronto, Toronto, Ontario, Canada., Hudani A; International Development, The University of Toronto, Toronto, Ontario, Canada., Kabiru J; Eye Unit, PCEA Kikuyu Hospital, Kikuyu, Kenya., Kimani K; Department of Ophthalmology, University of Nairobi, Nairobi, Kenya.; Kenyatta National Hospital, Nairobi, Kenya., Njuguna F; Department of Child Health and Paediatrics, Moi University, Eldoret, Kenya., Njambi L; Department of Ophthalmology, University of Nairobi, Nairobi, Kenya.; Kenyatta National Hospital, Nairobi, Kenya., Dimaras H; Human Biology Program, The University of Toronto, Toronto, Ontario, Canada.; Department of Ophthalmology and Vision Sciences, Faculty of Medicine, The University of Toronto, Toronto, Ontario, Canada.; Division of Clinical Public Health, Dalla Lana School of Public Health, The University of Toronto, Toronto, Ontario, Canada.; Department of Ophthalmology and Vision Sciences, The Hospital for Sick Children, Toronto, Ontario, Canada.; Child Health Evaluative Sciences Program, SickKids Research Institute, Toronto, Ontario, Canada.; Centre for Global Child Health, SickKids Research Institute, Toronto, Ontario, Canada.

Publikováno v: Journal of genetic counseling [J Genet Couns] 2024 Aug 01. Date of Electronic Publication: 2024 Aug 01.

Defining High-risk Retinoblastoma: A Multicenter Global Survey.

Autor: Kaliki S; Operation Eyesight Universal Institute for Eye Cancer, LV Prasad Eye Institute India, Hyderabad, India., Shields CL; Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania., Cassoux N; Department of Surgical Oncology, Insitut Curie Université de Paris, Paris, France., Munier FL; Jules-Gonin Eye Hospital, Fondation Asile des Aveugles, University of Lausanne, Lausanne, Switzerland., Chantada G; Oncology Department, Hospital Sant Joan de Déu, Barcelona, Spain., Grossniklaus HE; Department of Pathology, Emory University School of Medicine, Atlanta, Georgia., Yoshikawa H; Department of Ophthalmology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan., Fabian ID; Goldschleger Eye Institute, Sheba Medical Center, Tel Hashomer, Tel-Aviv University, Tel-Aviv, Israel., Berry JL; USC Roski Eye Institute, Keck School of Medicine of the University of Southern California, Los Angeles., McKenzie JD; Department of Ophthalmology, Royal Children's Hospital, Melbourne, Victoria, Australia., Kimani K; Department of Ophthalmology, University of Nairobi, Nairobi, Kenya., Reddy MA; Retinoblastoma Service, Royal London Hospital, Barts Health National Health Service Trust, London, United Kingdom., Parulekar M; Retinoblastoma Service, Birmingham Women's and Children's National Health Service Foundation Trust, Birmingham, United Kingdom., Tanabe M; Department of Ophthalmology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan., Furuta M; Department of Ophthalmology, Fukushima Medical University School of Medicine, Fukushima City, Fukushima, Japan., Grigorovski N; Department of Pediatric Oncology, Clinical Division, National Institute of Cancer, Rio de Janeiro, Brazil., Chevez-Barrios P; Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, Texas., Scanlan P; Department of Pediatrics, Muhimbili National Hospital, Dar es Salaam, Tanzania., Eagle RC Jr; Department of Pathology, Wills Eye Hospital, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, Pennsylvania., Rashid R; Department of Oculoplasty and Ocular Oncology, Ispahani Islamia Eye Institute and Hospital, Dhaka, Bangladesh., Coronado RD; Retinoblastoma Service, Instituto Nacional de Enfermedades Neoplasicas, Lima, Perú., Sultana S; Department of Oculoplasty and Ocular Oncology, Ispahani Islamia Eye Institute and Hospital, Dhaka, Bangladesh., Staffieri S; Department of Ophthalmology, Royal Children's Hospital, Melbourne, Victoria, Australia.; Retinoblastoma Service, Department of Surgery, University of Melbourne, Melbourne, Victoria, Australia.; Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, Melbourne, Victoria, Australia., Frenkel S; Division of Ophthalmology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel., Suzuki S; Department of Ophthalmic Oncology, National Cancer Center Hospital, Tokyo, Japan., Ushakova TL; Department of Pediatric Oncology and Hematology, N. N. Blokhin National Medical Research Center Oncology of Russian Federation, Moscow, Russia.; Retinoblastoma Service, Medical Academy of Postgraduate Education, Moscow, Russia., Ji X; Department of Ophthalmology, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Publikováno v: JAMA ophthalmology [JAMA Ophthalmol] 2022 Jan 01; Vol. 140 (1), pp. 30-36.

Evaluation of Entospletinib as a Novel Therapeutic Strategy Targeting Spleen Tyrosine Kinase in Retinoblastoma Treatment: An In-vitro Study.

Autor: KRISHNAKUMAR, SNEHA¹, ANUSHA, D.² anusha.d@sriramachandra.edu.in, KARTHIKA, K.³, KAVITHA, R.⁴

Publikováno v: Journal of Clinical & Diagnostic Research. Oct2024, Vol. 18 Issue 10, p1-4. 4p.

Lessons for Patient Engagement in Research in Low- and Middle-Income Countries.

Autor: Janic A; Institute of Medical Sciences, University of Toronto, Toronto, ON, Canada.; Department of Ophthalmology and Vision Sciences, The Hospital for Sick Children, Toronto, ON, Canada.; Child Health Evaluative Sciences Program, The Hospital for Sick Children, Toronto, ON, Canada.; The Centre for Global Child Health, SickKids Research Institute, Toronto, ON, Canada., Kimani K; Department of Ophthalmology, University of Nairobi, Nairobi, Kenya., Olembo I; Syndications and Agency Operations Department, Eastern and Southern African Trade and Development Bank, Nairobi, Kenya., Dimaras H; Institute of Medical Sciences, University of Toronto, Toronto, ON, Canada. helen.dimaras@sickkids.ca.; Department of Ophthalmology and Vision Sciences, The Hospital for Sick Children, Toronto, ON, Canada. helen.dimaras@sickkids.ca.; Child Health Evaluative Sciences Program, The Hospital for Sick Children, Toronto, ON, Canada. helen.dimaras@sickkids.ca.; The Centre for Global Child Health, SickKids Research Institute, Toronto, ON, Canada. helen.dimaras@sickkids.ca.; Department of Ophthalmology and Vision Sciences, University of Toronto, Toronto, ON, Canada. helen.dimaras@sickkids.ca.; Division of Clinical Public Health, University of Toronto, Toronto, ON, Canada. helen.dimaras@sickkids.ca.

Publikováno v: Ophthalmology and therapy [Ophthalmol Ther] 2020 Jun; Vol. 9 (2), pp. 221-229. Date of Electronic Publication: 2020 Mar 28.